PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
Titel:
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma
Auteur:
Smeester, Branden A. Slipek, Nicholas J. Pomeroy, Emily J. Laoharawee, Kanut Osum, Sara H. Larsson, Alex T. Williams, Kyle B. Stratton, Natalie Yamamoto, Kenta Peterson, Joseph J. Rathe, Susan K. Mills, Lauren J. Hudson, Wendy A. Crosby, Margaret R. Wang, Minjing Rahrmann, Eric P. Moriarity, Branden S. Largaespada, David A.